| Protocol | Title |
|---|---|
| BMTCTN0702 | A Trial of Single Autologous Transplant with or without Consolidation
Therapy versus Tandem Autologous Transplant with Lenalidomide
Maintenance for Patients with Multiple Myeloma
Activation Date: 10-jun-2010 |
| E1A10 | A Randomized Phase I/II Study of Bortezomib, Rituximab, Dexamethasone
and Temsirolimus in Patients with Relapsed Waldenstrom's
Macroglobulinemia and Relapsed/Refractory Mantle Cell, Follicular,
Marginal Zone or Small Lymphocytic Lymphomas (Phase I), and
Untreated/Relapsed Waldenstrom's Macroglobulinemia (PhaseII)
Activation Date: 20-jul-2011 Suspended: 23-may-2013 ECOG Participants(requires Adobe Acrobat) |
| E3A05 | Ancillary Laboratory Protocol for Collecting Diagnostic Material on
Patients Considered for Studies of Plasma Cell Disorders
Activation Date: 30-aug-2006 ECOG Participants(requires Adobe Acrobat) |
| E3A06 | Randomized Phase III Trial of Lenalidomide versus Observation Alone
in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma
Activation Date: 05-oct-2010 |
All contents copyright © 1998 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: 05/24/13